Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2016, Article ID 6312529, 7 pages
http://dx.doi.org/10.1155/2016/6312529
Research Article

Evaluation of Serum Vascular Adhesion Protein-1 as a Potential Biomarker in Thyroid Cancer

The Second Hospital of Hebei Medical University, No. 215 Heping West Road, Shijiazhuang, Hebei 050000, China

Received 8 April 2016; Revised 15 May 2016; Accepted 5 June 2016

Academic Editor: Giuseppe Damante

Copyright © 2016 Zhigang Hu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Z.-H. Zhou, X.-N. Cui, H.-G. Xing, R.-H. Yan, D.-K. Yao, and L.-X. Wang, “Changes and prognostic value of serum vascular endothelial growth factor in patients with differentiated thyroid cancer,” Medical Principles and Practice, vol. 22, no. 1, pp. 24–28, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Kunavisarut, “Diagnostic biomarkers of differentiated thyroid cancer,” Endocrine, vol. 44, no. 3, pp. 616–622, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. M. R. Castro and H. Gharib, “Continuing controversies in the management of thyroid nodules,” Annals of Internal Medicine, vol. 142, no. 11, pp. 926–931, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. J. E. Rosen and M. D. Stone, “Contemporary diagnostic approach to the thyroid nodule,” Journal of Surgical Oncology, vol. 94, no. 8, pp. 649–661, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer1, D. S. Cooper, G. M. Doherty et al., “Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer,” Thyroid, vol. 19, no. 11, pp. 1167–1214, 2009. View at Publisher · View at Google Scholar
  6. F. Pacini, M. Schlumberger, H. Dralle et al., “European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium,” European Journal of Endocrinology, vol. 154, no. 6, pp. 787–803, 2006. View at Publisher · View at Google Scholar
  7. L. Giovanella, L. Ceriani, A. Ghelfo, M. Maffioli, and F. Keller, “Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy,” Clinical Endocrinology, vol. 67, no. 4, pp. 547–551, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Robenshtok, R. K. Grewal, S. Fish, M. Sabra, and R. M. Tuttle, “A low postoperative nonstimulated serum thyroglobulin level does not exclude the presence of radioactive iodine avid metastatic foci in intermediate-risk differentiated thyroid cancer patients,” Thyroid, vol. 23, no. 4, pp. 436–442, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Merinen, H. Irjala, M. Salmi, I. Jaakkola, A. Hänninen, and S. Jalkanen, “Vascular adhesion protein-1 is involved in both acute and chronic inflammation in the mouse,” American Journal of Pathology, vol. 166, no. 3, pp. 793–800, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Salmi and S. Jalkanen, “Cell-surface enzymes in control of leukocyte trafficking,” Nature Reviews Immunology, vol. 5, no. 10, pp. 760–771, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. D. J. Smith, M. Salmi, P. Bono, J. Hellman, T. Leu, and S. Jalkanen, “Cloning of vascular adhesion protein 1 reveals a novel multifunctional adhesion molecule,” Journal of Experimental Medicine, vol. 188, no. 1, pp. 17–27, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Göktürk, J. Nilsson, J. Nordquist et al., “Overexpression of semicarbazide-sensitive amine oxidase in smooth muscle cells leads to an abnormal structure of the aortic elastic laminas,” American Journal of Pathology, vol. 163, no. 5, pp. 1921–1928, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. C. M. Stolen, G. G. Yegutkin, R. Kurkijärvi, P. Bono, K. Alitalo, and S. Jalkanen, “Origins of serum semicarbazide-sensitive amine oxidase,” Circulation Research, vol. 95, no. 1, pp. 50–57, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Salmi and S. Jalkanen, “A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans,” Science, vol. 257, no. 5075, pp. 1407–1409, 1992. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Salmi, S. Tohka, E. L. Berg, E. C. Butcher, and S. Jalkanen, “Vascular adhesion protein 1 (VAP-1) mediates lymphocyte subtype-specific, selectin-independent recognition of vascular endothelium in human lymph nodes,” The Journal of Experimental Medicine, vol. 186, no. 4, pp. 589–600, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Airas, J. Mikkola, J. M. Vainio, I. Elovaara, and D. J. Smith, “Elevated serum soluble vascular adhesion protein-1 (VAP-1) in patients with active relapsing remitting multiple sclerosis,” Journal of Neuroimmunology, vol. 177, no. 1-2, pp. 132–135, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Kurkijarvi, G. G. Yegutkin, B. K. Gunson, S. Jalkanen, M. Salmi, and D. H. Adams, “Circulating soluble vascular adhesion protein 1 accounts for the increased serum monoamine oxidase activity in chronic liver disease,” Gastroenterology, vol. 119, no. 4, pp. 1096–1103, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. M. A. Kaplan, M. Kucukoner, A. Inal et al., “Relationship between serum soluble vascular adhesion protein-1 level and gastric cancer prognosis,” Oncology Research and Treatment, vol. 37, no. 6, pp. 340–344, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Toiyama, C. Miki, Y. Inoue, A. Kawamoto, and M. Kusunoki, “Circulating form of human vascular adhesion protein-1 (VAP-1): Decreased serum levels in progression of colorectal cancer and predictive marker of lymphatic and hepatic metastasis,” Journal of Surgical Oncology, vol. 99, no. 6, pp. 368–372, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. S. T. Ward, C. J. Weston, E. L. Shepherd, R. Hejmadi, T. Ismail, and D. H. Adams, “Evaluation of serum and tissue levels of VAP-1 in colorectal cancer,” BMC Cancer, vol. 16, no. 1, article 154, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Yasuda, Y. Toiyama, M. Ohi, Y. Mohri, C. Miki, and M. Kusunoki, “Serum soluble vascular adhesion protein-1 is a valuable prognostic marker in gastric cancer,” Journal of Surgical Oncology, vol. 103, no. 7, pp. 695–699, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. S. B. Edge and C. C. Compton, “The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM,” Annals of Surgical Oncology, vol. 17, no. 6, pp. 1471–1474, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. H.-Y. Li, Y.-D. Jiang, T.-J. Chang et al., “Serum vascular adhesion protein-1 predicts 10-year cardiovascular and cancer mortality in individuals with type 2 diabetes,” Diabetes, vol. 60, no. 3, pp. 993–999, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Hocevar and M. Auersperg, “Role of serum thyroglobulin in the pre-operative evaluation of follicular thyroid tumours,” European Journal of Surgical Oncology, vol. 24, no. 6, pp. 553–557, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. N. B. Sands, S. Karls, J. Rivera et al., “Preoperative serum thyroglobulin as an adjunct to fine-needle aspiration in predicting well-differentiated thyroid cancer,” Journal of Otolaryngology—Head and Neck Surgery, vol. 39, no. 6, pp. 669–673, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Milhaud, C. Calmette, J. Taboulet, A. Julienne, and M. S. Moukhtar, “Letter: hypersecretion of calcitonin in neoplastic conditions,” The Lancet, vol. 1, no. 7855, pp. 462–463, 1974. View at Google Scholar
  27. P. Scheffler, V. I. Forest, R. Leboeuf et al., “Serum thyroglobulin improves the sensitivity of the McGill Thyroid nodule score for well-differentiated thyroid cancer,” Thyroid, vol. 24, no. 5, pp. 852–857, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Salmi and S. Jalkanen, “Human vascular adhesion protein 1 (VAP-1) is a unique sialoglycoprotein that mediates carbohydrate-dependent binding of lymphocytes to endothelial cells,” Journal of Experimental Medicine, vol. 183, no. 2, pp. 569–579, 1996. View at Publisher · View at Google Scholar · View at Scopus
  29. Y.-I. Li, J.-S. Hung, T.-Y. Yu et al., “Serum vascular adhesion protein-1 predicts all-cause mortality and cancer-related mortality in subjects with colorectal cancer,” Clinica Chimica Acta, vol. 428, pp. 51–56, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Irjala, M. Salmi, K. Alanen, R. Grénman, and S. Jalkanen, “Vascular adhesion protein 1 mediates binding of immunotherapeutic effector cells to tumor endothelium,” Journal of Immunology, vol. 166, no. 11, pp. 6937–6943, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Fukuhara, S. Kase, K. Noda et al., “Immunolocalization of vascular adhesion protein-1 in human conjunctival tumors,” Ophthalmic Research, vol. 48, no. 1, pp. 33–37, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. H. W. Chen, H. C. Huang, Y. S. Lin et al., “Comparison and identification of estrogen-receptor related gene expression profiles in breast cancer of different ethnic origins,” Breast Cancer, vol. 1, pp. 35–49, 2008. View at Google Scholar
  33. C. Sotiriou, S.-Y. Neo, L. M. McShane et al., “Breast cancer classification and prognosis based on gene expression profiles from a population-based study,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 18, pp. 10393–10398, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. M. B. Jensen, M. R. Chacon, J. A. Sattin, A. Aleu, and P. D. Lyden, “The promise and potential pitfalls of serum biomarkers for ischemic stroke and transient ischemic attack,” Neurologist, vol. 14, no. 4, pp. 243–246, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. J. E. Barroeta, Z. W. Baloch, P. Lal, T. L. Pasha, P. J. Zhang, and V. A. LiVolsi, “Diagnostic value of differential expression of CK19, galectin-3, HBME-1, ERK, RET, and p16 in benign and malignant follicular-derived lesions of the thyroid: an immunohistochemical tissue microarray analysis,” Endocrine Pathology, vol. 17, no. 3, pp. 225–234, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Y. Liu, H. Morreau, J. Kievit, J. A. Romijn, N. Carrasco, and J. W. Smit, “Combined immunostaining with galectin-3, fibronectin-1, CITED-1, Hector Battifora mesothelial-1, cytokeratin-19, peroxisome proliferator-activated receptor-γ, and sodium/iodide symporter antibodies for the differential diagnosis of non-medullary thyroid carcinoma,” European Journal of Endocrinology, vol. 158, no. 3, pp. 375–384, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. J. P. Young, H. K. Soo, C. K. Dong et al., “Diagnostic value of galectin-3, HBME-1, cytokeratin 19, high molecular weight cytokeratin, cyclin D1 and p27kip1 in the differential diagnosis of thyroid nodules,” Journal of Korean Medical Science, vol. 22, no. 4, pp. 621–628, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Ito, Y. E. Nikiforov, M. Schlumberger, and R. Vigneri, “Increasing incidence of thyroid cancer: controversies explored,” Nature Reviews Endocrinology, vol. 9, no. 3, pp. 178–184, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Wu, X. Yue, W. Shen et al., “Diagnostic value of diffusion-weighted MR imaging in thyroid disease: application in differentiating benign from malignant disease,” BMC Medical Imaging, vol. 13, no. 1, article 23, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. E. K. Lee, K.-W. Chung, H. S. Min et al., “Preoperative serum thyroglobulin as a useful predictive marker to differentiate follicular thyroid cancer from benign nodules in indeterminate nodules,” Journal of Korean Medical Science, vol. 27, no. 9, pp. 1014–1018, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Al-Bader, F. Zawawi, Z. Singer et al., “Preoperative TSH and thyroglobulin levels: would it predict thyroid cancer?” Otolaryngologia Polska, vol. 69, no. 3, pp. 21–25, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Gupta, P. S. Choudhury, S. Nag, and P. Gupta, “Stimulated high serum thyroglobulin with negative whole body imaging do not warrant an aggressive diagnostic and therapeutic approach in differentiated thyroid cancer patients: a follow-up of 5 years or till recurrence,” Hellenic Journal of Nuclear Medicine, vol. 18, no. 3, pp. 207–214, 2015. View at Google Scholar · View at Scopus
  43. J. Zheng, C. Li, W. Lu, C. Wang, and Z. Ai, “Quantitative assessment of preoperative serum thyrotropin level and thyroid cancer,” Oncotarget, 2016. View at Publisher · View at Google Scholar
  44. M. Hedayati, Z. Nozhat, and M. Hannani, “Can the serum level of myostatin be considered as an informative factor for cachexia prevention in patients with medullary thyroid cancer?” Asian Pacific Journal of Cancer Prevention, vol. 17, pp. 119–123, 2016. View at Google Scholar
  45. Y. Y. Cho, H. W. Jang, J. Y. Jang et al., “Clinical outcomes of patients with hypercalcitoninemia after initial treatment for medullary thyroid cancer and postoperative serum calcitonin cutoffs for predicting structural recurrence,” Head & Neck, 2016. View at Publisher · View at Google Scholar
  46. Y. P. Zhao, W. Wang, X. H. Wang et al., “Downregulation of serum DKK-1 predicts poor prognosis in patients with papillary thyroid cancer,” Genetics and Molecular Research, vol. 14, no. 4, pp. 18886–18894, 2015. View at Publisher · View at Google Scholar · View at Scopus
  47. J.-H. Shi, Y.-Y. Xu, Q.-Z. Pan, G.-Q. Sui, J.-P. Zhou, and H. Wang, “The value of combined application of ultrasound-guided fine needle aspiration cytology and thyroglobulin measurement for the diagnosis of cervical lymph node metastases from thyroid cancer,” Pakistan Journal of Medical Sciences, vol. 31, no. 5, pp. 1152–1155, 2015. View at Publisher · View at Google Scholar · View at Scopus